1.
Yield and costs of molecular diagnostics on thyroid cytology slides in the Netherlands, adapting the Bethesda classification
IGF‐1 as screening tool for acromegaly and adult‐onset growth hormone deficiency in the Netherlands
Correction: Once-weekly semaglutide for patients with type 2 diabetes: a cost-effectiveness analysis in the Netherlands
Mining treatment patterns of glucose-lowering medications for type 2 diabetes in the Netherlands
Diabetes patient preferences for glucose-monitoring technologies: results from a discrete choice experiment in Poland and the Netherlands
Prognostic factors and survival in MEN1 patients with gastrinomas : Results from the DutchMEN study group (DMSG)
2.
3.
Prognostic factors and survival in MEN1 patients with gastrinomas: Results from the DutchMEN study group (DMSG)
4.
5.
Germline founder variant c.1998delinsTTCT in the RET oncogene: a cohort study in 15 Belgian families
6.